Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy

被引:39
|
作者
Obaro, SK
Deubzer, HE
Newman, VO
Adegbola, RA
Greenwood, BM
Henderson, DC
机构
[1] MRC Labs, Banjul, Gambia
[2] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London, England
[3] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England
关键词
pneumococcal polysaccharide vaccine; pregnancy; breast milk; infant;
D O I
10.1097/01.inf.0000143651.54880.09
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In breast-feeding populations, immunization during pregnancy with pneumococcal polysaccharide offers a potentially useful approach to preventing pneumococcal disease in young infants. Methods: Breast milk samples were collected at 0, 2, 4 and 6 months after delivery from Gambian women vaccinated during pregnancy (24-32 weeks gestation) with Pneumovax II (n = 56) or Mengivax A&C (n = 57). Specimens were examined for secretory immunoglobulin A (s-IgA) concentration, subclass distribution and avidity specific to pneumococcal serotypes 4, 6B, 14, 19F and 23F and the antigen mixture in Pneumovax 11 by enzyme-linked immunosorbent assay. Colostral s-IgA and IgG concentrations in paired maternal sera were compared. Results: Colostral s-IgA concentrations specific to all pneumococcal polysaccharide antigens investigated were significantly higher (P < 0.05) among Pneumovax II vaccinees. Titers specific to serotypes 4, 6B and 14 and the vaccine formula remained significantly higher during 6 months, and those for 19F were higher during 4 months. Significantly higher concentrations of vaccine antigen-specific s-IgA antibody were sustained for 6 months after delivery (P = 0.011). Comparison of colostral s-IgA and IgG in serum revealed a significant correlation only among Mengivax A&C vaccinees for pneumococcal polysaccharide 23F (r(s) = 0.68; P less than or equal to 0.0001). Vaccination elicited trends toward increased s-IgA2, reaching significance for serotype 14 and the vaccine formula. Immunization elicited significantly higher s-IgA avidities specific to all pneumococcal polysaccharide antigens studied during 6 months. Conclusions: The public health value of immunization during pregnancy with pneumococcal polysaccharide vaccine in breastfeeding populations warrants further evaluation, particularly in populations with a high incidence of pneumococcal disease in early infancy.
引用
收藏
页码:1023 / 1029
页数:7
相关论文
共 50 条
  • [21] Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, Denmark
    Nielsen, Katrine Finderup
    Nielsen, Lise Birk
    Dalby, Tine
    Lomholt, Frederikke Kristensen
    Slotved, Hans-Christian
    Fuursted, Kurt
    Harboe, Zitta Barrella
    Jorgensen, Charlotte Svaerke
    Valentiner-Branth, Palle
    EMERGING INFECTIOUS DISEASES, 2024, 30 (06) : 1164 - 1172
  • [22] Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
    Feikin, Daniel R.
    Kagucia, Eunice W.
    Loo, Jennifer D.
    Link-Gelles, Ruth
    Puhan, Milo A.
    Cherian, Thomas
    Levine, Orin S.
    Whitney, Cynthia G.
    O'Brien, Katherine L.
    Moore, Matthew R.
    PLOS MEDICINE, 2013, 10 (09)
  • [23] Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months
    Russell, F. M.
    Balloch, A.
    Licciardi, P. V.
    Carapetis, J. R.
    Tikoduadua, L.
    Waqatakirewa, L.
    Cheung, Y. B.
    Mulholland, E. K.
    Tang, M. L. K.
    VACCINE, 2011, 29 (27) : 4499 - 4506
  • [24] Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan
    Nisar, Muhammad Imran
    Jehan, Fyezah
    Shahid, Shahira
    Ahmed, Sheraz
    Shakoor, Sadia
    Kabir, Furqan
    Hotwani, Aneeta
    Muneer, Sahrish
    Khalid, Farah
    Muhammad, Sajid
    Althouse, Benjamin M.
    Hu, Hao
    Whitney, Cynthia G.
    Ali, Asad
    Zaidi, Anita K. M.
    Omer, Saad B.
    Iqbal, Najeeha
    PLOS ONE, 2022, 17 (01):
  • [25] Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease
    Ohshima, Nobuharu
    Nagai, Hideaki
    Matsui, Hirotoshi
    Akashi, Shunsuke
    Makino, Tomohiko
    Akeda, Yukihiro
    Oishi, Kazunori
    VACCINE, 2014, 32 (10) : 1181 - 1186
  • [26] Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: Effects of continued penicillin prophylaxis
    Bjornson, AB
    Falletta, JM
    Verter, JI
    Buchanan, GR
    Miller, ST
    Pegelow, CH
    Iyer, RV
    Johnstone, HS
    DeBaun, MR
    Wethers, DL
    Wang, WC
    Woods, GM
    Holbrook, CT
    Becton, DL
    Kinney, TR
    Reaman, GH
    Kalinyak, K
    Grossman, NJ
    Vichinsky, E
    Reid, CD
    JOURNAL OF PEDIATRICS, 1996, 129 (06): : 828 - 835
  • [27] Role of Dectin-2 in the serotype-specific antibody production and host protection against Streptococcus pneumoniae infection caused by pneumococcal polysaccharide vaccine
    Miyasaka, Tomomitsu
    Akahori, Yukiko
    Miyamura, Namiko
    Toyama, Masahiko
    Saijo, Shinobu
    Iwakura, Yoichiro
    Kinjo, Yuki
    Oishi, Kazunori
    Kawakami, Kazuyoshi
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [28] Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure
    Ladhani, Shamez
    Borrow, Ray
    Heath, Paul T.
    Ramsay, Mary E.
    Booy, Robert
    VACCINE, 2010, 28 (28) : 4440 - 4444
  • [29] Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study
    Suzuki, Motoi
    Dhoubhadel, Bhim Gopal
    Ishifuji, Tomoko
    Yasunami, Michio
    Yaegashi, Makito
    Asoh, Norichika
    Ishida, Masayuki
    Hamaguchi, Sugihiro
    Aoshima, Masahiro
    Ariyoshi, Koya
    Morimoto, Konosuke
    LANCET INFECTIOUS DISEASES, 2017, 17 (03): : 313 - 321
  • [30] Ineffectiveness for Infants of Immunization of Mothers with Pneumococcal Capsular Polysaccharide Vaccine During Pregnancy
    Lopes, Claudia R. C.
    Berezin, Eitan N.
    Ching, Ting Hui
    Canuto, Jaildo de Souza
    da Costa, Vanilda Oliveira
    Klering, Erika Monteiro
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (02): : 104 - 106